Tumor markers in non-malignant diseases.

[1]  D. Pittaway,et al.  The use of CA-125 in the diagnosis and management of endometriosis. , 1986, Fertility and sterility.

[2]  W. Mastropaolo,et al.  Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation. , 1986, Clinical chemistry.

[3]  V. Zurawski,et al.  Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Klug,et al.  CA 19-9 and CA 125 levels in the sera of normal blood donors in relation to smoking history. , 1986, Journal of the National Cancer Institute.

[5]  Á. Ruibal,et al.  CA 15.3: early results of a new breast cancer marker. , 1986, Anticancer research.

[6]  H. Egami,et al.  Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant Women , 1986, The American journal of the medical sciences.

[7]  H. Egami,et al.  Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System , 1986, The American journal of the medical sciences.

[8]  P. Patton,et al.  CA-125 levels in endometriosis. , 1986, Fertility and sterility.

[9]  R. Bast,et al.  Elevated serum concentrations of CA-125 in patients with advanced endometriosis. , 1986, Fertility and sterility.

[10]  U. Stenman,et al.  Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy , 1986, Cancer.

[11]  J. Bidart,et al.  CA 125 (ovarian tumour-associated antigen) in ascitic liver diseases. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[12]  B. Descottes,et al.  [Carbohydrate antigen CA 19-9: value in pancreatic pathology]. , 1986, Gastroenterologie clinique et biologique.

[13]  M. Büchler,et al.  CA 19‐9 and pancreatic adenocarcinoma , 1986, Cancer.

[14]  Y. Chung,et al.  Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases. , 1985, The American journal of gastroenterology.

[15]  T. Briers,et al.  Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. , 1985, Clinical chemistry.

[16]  Y. Arakawa,et al.  Determination and significance of a new carbohydrate antigen CA19-9 in digestive system cancers. , 1985, Japanese journal of medicine.

[17]  Y. Chung,et al.  A clinical evaluation of carbohydrate antigen 19‐9 and carcinoembryonic antigen in patients with pancreatic carcinoma , 1985, Journal of surgical oncology.

[18]  A. Piccoli,et al.  CA 19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. , 1985, European journal of cancer & clinical oncology.

[19]  R. Bast,et al.  CA125 Antigen Levels in Obstetric and Gynecologic Patients , 1984, Obstetrics and gynecology.

[20]  O. Nilsson,et al.  Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. , 1984, British medical journal.

[21]  R. Bast,et al.  Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. , 1984, American journal of obstetrics and gynecology.

[22]  T. Klug,et al.  Initial clinical evaluation of an immunoradiometric assay for CA 19‐9 using the nci serum bank , 1984, International journal of cancer.

[23]  J. Nakache,et al.  Cumulative effects of age and pathology on plasma carcinoembryonic antigen in an unselected elderly population. , 1984, European journal of cancer & clinical oncology.

[24]  R. Bast,et al.  Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. , 1984, Cancer research.

[25]  C. Haglund,et al.  Comparison of a new tumour marker, CA 199TM, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases , 2004 .

[26]  H. Koprowski,et al.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.

[27]  R. Bast,et al.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. , 1983, The New England journal of medicine.

[28]  O. Nilsson,et al.  Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. , 1983, International archives of allergy and applied immunology.

[29]  V. Zurawski,et al.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. , 1983, Clinical chemistry.

[30]  M. Brockhaus,et al.  A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. , 1982, The Journal of biological chemistry.

[31]  M. Herlyn,et al.  Gastrointestinal cancer-associated antigen in immunoperoxidase assay. , 1982, Cancer research.

[32]  R. Bast,et al.  Reactivity of a monoclonal antibody with human ovarian carcinoma. , 1981, The Journal of clinical investigation.

[33]  M. Brockhaus,et al.  A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. , 1981, Science.

[34]  M. Herlyn,et al.  Specific antigen in serum of patients with colon carcinoma. , 1981, Science.

[35]  H. Kato,et al.  Tumor antigen of human cervical squamous cell carcinoma. Correlation of circulating levels with disease progress , 1979, Cancer.

[36]  H. Kato,et al.  Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma , 1977, Cancer.

[37]  E. Barton.  ART. II. Account of the Epidemic Fellow Fever which prevailed in New Orleans during the Autumn of 1833 , 1834 .

[38]  Y. Touitou,et al.  [Critical study of current tumoral markers]. , 1988, Bulletin du cancer.

[39]  T. Yoshikawa,et al.  Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies. , 1985, Digestion.

[40]  Á. Ruibal,et al.  CA125 seric levels in non malignant pathologies. , 1984, Bulletin du cancer.

[41]  J. Douillard,et al.  Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA. , 1984, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[42]  Á. Ruibal,et al.  Clinical interest of seric CA19.9 determination in differential diagnosis of patients with peptic ulcers and gastric cancer. , 1983, Bulletin du cancer.

[43]  R. Bast,et al.  Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types. , 1983, American journal of clinical pathology.